Outset End Period Cash Flow from 2010 to 2025

OM Stock  USD 0.80  0.01  1.23%   
Outset Medical End Period Cash Flow yearly trend continues to be very stable with very little volatility. End Period Cash Flow is likely to grow to about 140 M this year. During the period from 2010 to 2025, Outset Medical End Period Cash Flow quarterly data regression pattern had sample variance of 7000.5 T and median of  33,415,000. View All Fundamentals
 
End Period Cash Flow  
First Reported
2019-06-30
Previous Quarter
37.9 M
Current Value
36.6 M
Quarterly Volatility
110.7 M
 
Covid
Check Outset Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Outset Medical's main balance sheet or income statement drivers, such as Tax Provision of 631.5 K, Interest Income of 12.3 M or Depreciation And Amortization of 4.9 M, as well as many indicators such as Price To Sales Ratio of 2.25, Dividend Yield of 0.0 or PTB Ratio of 2.06. Outset financial statements analysis is a perfect complement when working with Outset Medical Valuation or Volatility modules.
  
Check out the analysis of Outset Medical Correlation against competitors.
To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.

Latest Outset Medical's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Outset Medical over the last few years. It is Outset Medical's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Outset Medical's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Outset End Period Cash Flow Regression Statistics

Arithmetic Mean78,330,426
Geometric Mean55,788,542
Coefficient Of Variation106.82
Mean Deviation56,648,764
Median33,415,000
Standard Deviation83,668,709
Sample Variance7000.5T
Range294.9M
R-Value0.49
Mean Square Error5726.8T
R-Squared0.24
Significance0.06
Slope8,545,919
Total Sum of Squares105006.8T

Outset End Period Cash Flow History

2025140 M
202482.6 M
202371.8 M
202276.5 M
2021215.7 M
2020328.3 M
201937.7 M

About Outset Medical Financial Statements

Outset Medical investors utilize fundamental indicators, such as End Period Cash Flow, to predict how Outset Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow82.6 M140 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out the analysis of Outset Medical Correlation against competitors.
To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.74)
Revenue Per Share
2.235
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.27)
Return On Equity
(1.41)
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Outset Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.